NasdaqCM - Delayed Quote • USD
NeuBase Therapeutics, Inc. (NBSE)
At close: April 18 at 4:00 PM EDT
Major Holders
| Breakdown | |
|---|---|
| 13.38% | % of Shares Held by All Insider |
| 12.69% | % of Shares Held by Institutions |
| 14.64% | % of Float Held by Institutions |
| 25 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Greenlight Capital, Inc. | 136.35k | Dec 31, 2023 | 3.63% | 59,121 |
| UBS Group AG | 65.72k | Dec 31, 2023 | 1.75% | 28,497 |
| Point72 Asset Management, L.P. | 62.5k | Dec 31, 2023 | 1.67% | 27,100 |
| Renaissance Technologies, LLC | 56.97k | Dec 31, 2023 | 1.52% | 24,700 |
| Carnegie Mellon University | 46.97k | Dec 31, 2023 | 1.25% | 20,366 |
| Two Sigma Investments, LP | 21.08k | Dec 31, 2023 | 0.56% | 9,141 |
| Vanguard Group Inc | 18.98k | Dec 31, 2023 | 0.51% | 8,230 |
| Kestra Advisory Services, LLC | 16.48k | Dec 31, 2023 | 0.44% | 7,143 |
| Jacob Asset Management of New York LLC | 15.65k | Sep 30, 2023 | 0.42% | 6,788 |
| Prelude Capital Management LLC | 15.55k | Dec 31, 2023 | 0.41% | 6,742 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 18.98k | Dec 31, 2023 | 0.51% | 8,230 |
| Jacob Discovery Fd | 15.65k | Feb 29, 2024 | 0.42% | 6,788 |
| Fidelity Extended Market Index Fund | 11.22k | Feb 29, 2024 | 0.30% | 4,863 |
| Fidelity Series Total Market Index Fund | 1.43k | Feb 29, 2024 | 0.04% | 617 |
| Fidelity Total Market Index Fund | 1.36k | Feb 29, 2024 | 0.04% | 589 |
| Fidelity NASDAQ Composite Index Fund | 985 | Feb 29, 2024 | 0.03% | 427 |
Related Tickers
MNOV MediciNova, Inc.
1.4000
-2.10%
ESLA Estrella Immunopharma, Inc.
1.0300
-8.04%
NLSP NLS Pharmaceutics Ltd.
0.1327
-0.23%
FRES Fresh2 Group Limited
0.3385
-3.31%
WINT Windtree Therapeutics, Inc.
0.3398
-14.21%
MACK Merrimack Pharmaceuticals, Inc.
14.68
0.00%
DMAC DiaMedica Therapeutics Inc.
2.4900
-4.23%
OKYO OKYO Pharma Limited
1.4653
+3.19%
BLPH Bellerophon Therapeutics, Inc.
0.0571
+4.77%
MRKR Marker Therapeutics, Inc.
4.1002
-3.07%